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Replication of alphaviruses strongly depends on the promoters located in the plus- and minus-strands of virus-specific RNAs. The most
sophisticated promoter is encoded by the 5′ end of the viral genome. This RNA sequence is involved in the initiation of translation of viral nsPs,
and synthesis of both minus- and plus-strands of the viral genome. Part of the promoter, the 51-nt conserved sequence element (CSE), is located in
the nsP1-coding sequence, and this limits the spectrum of possible mutations that can be performed. We designed a recombinant Venezuelan
equine encephalitis virus genome, in which the promoter and nsP1-coding sequences are separated. This modification has allowed us to perform a
wide variety of genetic manipulations, without affecting the amino acid sequence of the nsPs, and to further investigate 51-nt CSE functioning.
The results of this study suggest a direct interaction of the amino terminal domain of nsP2 with the 5′ end of the viral genome.
© 2007 Elsevier Inc. All rights reserved.Keywords: RNA replication; 51-nt CSE; Venezuelan equine encephalitis virusIntroduction
The alphavirus genus of the Togaviridae family contains
almost 30 members, some of which are important human and
animal pathogens (Griffin, 2001; Strauss and Strauss, 1994).
Alphaviruses are widely distributed on all continents except in
the Arctic and Antarctic areas. They efficiently replicate both in
mosquito vectors and vertebrate hosts. However, in mosquitoes
they cause a persistent, lifelong infection that does not
noticeably affect biological functions of the vectors, while in
vertebrate hosts, the infection is acute and characterized by
high-titer viremia, rash and fever, until the virus is cleared by
the immune system. The New World alphaviruses can cause
severe encephalitis in humans and animals that can result in
death or neurological disorders (Dal Canto and Rabinowitz,
1981; Griffin, 2001; Johnston and Peters, 1996; Leon, 1975).
These encephalitogenic alphaviruses include Venezuelan
(VEEV), eastern (EEEV) and western equine encephalitis
(WEEV) viruses and represent a serious public health threat in
the US (Rico-Hesse et al., 1995; Weaver and Barrett, 2004;⁎ Corresponding author. Fax: +1 409 772 5065.
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Central, South and North Americas and cause severe, and
sometimes fatal disease in humans and horses. During VEEV
epizootics, equine mortality due to encephalitis can reach 83%,
and in humans, while the overall mortality rate is below 1%,
neurological disease including disorientation, ataxia, mental
depression and convulsions, can be detected in up to 14% of all
infected individuals, especially children (Johnson and Martin,
1974). Sequelae of VEEV-related clinical encephalitis in humans
and rats are also described (Garcia-Tamayo et al., 1979; Leon,
1975). In spite of the continuous threat of VEEV epidemics, the
biology of this virus and the mechanism of its replication are
insufficiently understood.
The VEEV genome is represented by a ca. 11.5 kb-long,
single-stranded RNA of positive polarity (Strauss et al., 1984),
which mimics the structure of the cellular mRNAs, in that it
contains a 5′ cap and poly(A)-tail at the 5′ and 3′ ends,
respectively. The genome contains two polyprotein-coding
sequences. The first, a 7500 nt-long, 5′-terminal open reading
frame (ORF) is translated into viral nonstructural proteins
(nsP1–4) that form, together with the cellular proteins, the
enzyme complex required for genome replication and transcrip-
tion of the subgenomic RNA. The latter RNA encodes the
476 G. Michel et al. / Virology 362 (2007) 475–487second polyprotein that is co- and post-translationally processed
into viral structural proteins (capsid, E2 and E1) that form
infectious viral particles.
The replication of the alphavirus genome is a multi-step
process that begins with synthesis of a full-length, minus-strand
RNA intermediate that, in turn, serves as a template for
synthesis of the plus-strand viral genomes and transcription of
the subgenomic RNA. Synthesis of these RNA species is a
highly synchronized process regulated by differential proces-
sing of the viral nsPs (Lemm and Rice, 1993; Lemm et al.,
1994; Shirako and Strauss, 1994). At the early stages of viral
replication, the ns polyprotein is partially processed by nsP2-
associated protease into P123 and nsP4, an enzyme complex
capable of minus-, but not plus-strand RNA synthesis. Then,
after further processing of the polyproteins into nsP1+P23+
nsP4, the intermediate polymerase functions in synthesis of
both plus and minus genome-sized RNA, but appears to be
unable to efficiently use the internal promoter for 26S mRNA
synthesis. Finally, after complete P1234 processing to indivi-
dual nsP1–4, the replication complex (RC) efficiently (Wang et
al., 1994) synthesizes the plus-strand viral genome and
subgenomic RNA, but is no longer capable of minus-strand
synthesis (Lemm et al., 1994, 1998; Sawicki and Sawicki,
1987). Thus, the early and mature RCs most likely utilize
different RNA promoters located in the plus- and minus-strands
of virus-specific RNAs.
The critical element of the promoter for minus-strand RNA
synthesis is a 19-nt-long, conserved sequence element (CSE)
adjacent to the poly(A) and located at the 3′ end of the viral
genome (Hardy, 2006; Hardy and Rice, 2005; Kuhn et al.,
1990). The mutations in this sequence have a deleterious effect
on alphavirus replication. However, it can be replaced by an
artificial AU-rich sequence that might efficiently function in
RNA synthesis (Raju et al., 1999). It was also demonstrated that
the presence of poly(A) at the 3′-terminus and cap at the 5′
terminus strongly stimulates the RNA replication (Hardy and
Rice, 2005). Moreover, the sequence of the 5′UTR determines
the minus-strand RNA synthesis as well (Frolov et al., 2001;
Gorchakov et al., 2004), and these facts strongly suggest the
importance of the 5′–3′ end interaction in the RNA replication,
which most likely proceeds through formation of the translation
initiation complex. The subgenomic promoter required for
transcription of the subgenomic RNA is well defined (Levis et
al., 1990; Ou et al., 1983; Wielgosz et al., 2001) and represented
by a 24-nt CSE located in the minus-strand genome
intermediate. The latter CSE covers not only the nucleotides
adjacent to the start of the subgenomic RNA, but the first
nucleotides of the subgenomic RNA as well. This promoter is
recognized in vitro by the protein complex containing all of the
viral nsPs (Li and Stollar, 2004).
The most sophisticated promoter of the RNA synthesis is
encoded by the 5′ end of the alphavirus genome. Its functioning
was intensively studied in the context of Sindbis virus (SINV)
(Fayzulin and Frolov, 2004; Gorchakov et al., 2004; Niesters
and Strauss, 1990a, 1990b; Strauss and Strauss, 1994), but is
still poorly understood. The 5′ terminus appears to contain two
elements: the 5′-terminal sequence, encoded by the 5′UTR (thatappears to represent a core promoter) and a 51-nt CSE, found in
the nsP1-coding sequence that might be a replication enhancer,
functioning in a virus- and cell-dependent manner (Fayzulin and
Frolov, 2004; Niesters and Strauss, 1990b). The problem with
investigation of the 5′ promoter lies in the involvement of its
sequence in initiation of translation of viral nsPs, and synthesis
of both minus- and plus-strands of the viral genome. In addition,
part of the promoter, the 51-nt CSE, is located in the nsP1-
coding sequence, and this strongly limits a spectrum of
mutations that can be done without affecting nsP1 functioning.
We considered these difficulties when we undertook the
VEEV promoter investigation and designed a VEEV genome,
in which the promoter sequence and the nsP1-coding sequence
are separated. This modification allowed us to both perform a
wide variety of genetic manipulations without affecting the
amino acid sequence of the nsPs, and study the function of 51-nt
CSE in virus replication. The results of this study suggest a
direct interaction of the amino terminal domain of VEEV nsP2
with the 5′ end of the viral RNA and a possibility of applying a
similar approach in studying the 5′-terminal promoter function-
ing in replication of other RNA-positive viruses.
Results
Recombinant viruses with the 5′ promoter sequences located
outside of the nsPs’ ORF
In our initial experiments, we attempted to develop an
experimental system to study the effect of extended genetic
manipulations in the 5′-terminal alphavirus genome elements
without affecting the amino acid (a.a.) sequence of the nsPs.
Thus, we separated the 5′ end-specific promoter and the nsP-
coding sequence in the context of the VEEV TC-83 genome. To
achieve this, we introduced 95 mutations into the first 300 nt of
the nsP1-coding gene of VEEVmut (Fig. 1A), and these
mutations did not change the encoded protein sequence.
However, based on computer predictions, they destroyed the
original secondary structure of the fragment, including the
secondary structure of the 51-nt CSE. After transfection of the
in vitro-synthesized RNA into BHK-21 cells, no cytopathic
effect (CPE) was detected and no infectious virus was recovered
even after following blind passages of the harvested media on
the naive BHK-21 cells (data not shown). This indicated that the
introduced mutations and, most likely, the destabilization of the
secondary structure made the genome RNA incapable of
replication, and neither the reverting nor pseudoreverting
mutations accumulated in the VEEVmut genome.
In the next step, we cloned a 347-nt-long 5′-terminal
fragment of the VEEV TC-83 genome into the VEEVmut
genome upstream from the initiating AUG (see Figs. 1A and B
for details). In the VEEVubi, fusion of the cloned sequence and
the nsP1 was performed through the ubiquitin (Ubi) gene to
preserve synthesis of the following nsP1 protein in its natural
form, including the first methionine. Thus, the ORF started from
the AUG located downstream from the 5′UTR and continued
through the cloned fragment of nsP1 and Ubi into the P1234
polyprotein.
Fig. 1. Replication of VEEV and SINV viruses with modified 5′ ends of the genome in BHK-21 and C710 cells. (A) Schematic representation of VEEV and SINV
genomes with modified 5′ ends, and infectivities of the in vitro-synthesized viral RNAs in the infectious center assay. Solid boxes indicate the nsP1 sequence
containing clustered silent mutations. Arrows indicate position of the subgenomic promoter. N.A. indicates “not applicable,” because of the wt phenotype of the
designed mutants. (B and C) Schematic representation of the 5′ ends of VEEVubi and SINVubi genomes, respectively. Solid boxes indicate nsP1 sequence containing
clustered silent mutations. Arrows indicate positions of the initiating AUG in the computer-predicted secondary structure and starting AUG of the nsP1–4 polyprotein.
(D and E, F and G) Single-step viral growth curves after electroporation of 3 μg of in vitro-synthesized RNAs into BHK-21 or C710 cells. At the indicated times, the
medium was replaced, and virus titers were determined in BHK-21 cells, as described in Materials and methods. The dashed lines indicate the limit of detection.
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same infectivity as did the in vitro-synthesized genome of
VEEV TC-83 (Fig. 1A). The harvested virus formed plaques
that were of the same size as those formed by VEEV TC-83 and
replicated at essentially the same rate as did the latter wt virus in
both BHK-21 and mosquito C710 cells (Figs. 1D and E). Taken
together, these data indicated that by cloning a wt 5′ end, we
restored the virus ability to efficiently replicate. The recombi-
nant genome could be further used for extended deletions and
insertions in the promoter region, including the 51-nt CSE,
without affecting the amino acid sequence of nsP1. Most
importantly, we attained a possibility of deleting the predicted,
promoter-specific stem–loops without causing deleterious
changes in the secondary structure of the entire 5′ end. The
only restriction that had to be met was conservation of the ORF
during modifications: the translation had to start on the initiating
AUG and continue into P1234 through the Ubi.
Interestingly, we were unable to prevent SINV replication by
introducing a similar set of mutations into the beginning of the
nsP1-coding sequence. In spite of the presence of 97 silent
clustered mutations that completely destroyed the secondary
structure of the 5′ end of SINV genome, the designed SINVmut
(see Figs. 1A and B for details) was capable of replication in
both BHK-21 and C710 cells albeit to dramatically lower titers
(Figs. 1F and G). It formed heterogeneous plaques, suggesting
an accumulation of the adaptive mutations that increased the
replication rates. After inserting the wt 5′-terminal SINV ge-
nome sequence and Ubi gene upstream from the mutated nsP1,
the recombinant virus (SINVubi) became indistinguishable
from the wt SINV Toto1101, and, as expected, the insertion of
the mutated nsP1 sequence containing the same 97 silent
mutations did not increase the rate of virus (SINVmutUbi)
replication (Figs. 1A, C, F and G). These data indicated that the
nucleotide sequence located downstream from the 5′-terminal
stem–loops 1 and 2 (and including the 51-nt CSE) plays a
critical role in VEEV replication, but has a less significant role
in replication of SINV. The latter virus is capable of replication
even if this sequence contains clustered mutations that destroy
the secondary structure of more than 300-nt-long 5′-terminal
fragment of the viral genome. The residual activity of the 5′
UTR-associated basal promoter appears to be sufficient for
replication of the mutated virus at detectable levels.
The stem–loops in the VEEV 51-nt CSE have redundant
functions in RNA replication
The development of VEEVubi opened an opportunity to
perform extended mutagenesis of the 5′-terminal promoter
elements in the viral genome by deleting the predicted particular
structural elements without affecting the others. We provision-
ally divided the VEEV 5′ terminus into 5 elements that re-
presented (1) the very 5′-terminal stem–loop (nt 4–26); (2) the
large stem–loop containing the initiating AUG (nt 36–126); (3
and 4) two small stem–loops containing the 51-nt CSE (nt 133–
158 and 162–184); and (5) the 162 nt-long sequence located
between the 51-nt CSE and Ubi. All of the deletions were done
according to this prediction. They were designed to save theORF starting at nt 45, and the stem–loops 1 and 2 were not
deleted in any constructs to conserve the efficiency of nsPs
translation at the level of the wt virus genome (however, the
translation efficiency was not experimentally evaluated).
The deletion of elements 3 or 4, or 5 did not have a
deleterious effect on virus replication. In the infectious center
assay, the in vitro-synthesized viral RNAs were as infectious as
that of VEEVubi (Fig. 2A). However, there was a noticeable
decrease in RNA replication (Fig. 2B) and slower rates of
infectious virus release after transfection of both BHK-21 and
C710 cells (Figs. 2C and D). Moreover, the deletion of stem–
loop 3 had the strongest effect on virus production. At any time
post transfection, titers of VEEVubiΔ3 were 10- to 100-fold
lower than were those of VEEVubi. Thus, these three elements
were involved in VEEV replication, but likely had redundant
functions, and the presence of any two of them in the viral
genome was sufficient for supporting efficient replication.
However, deletion of the entire 51-nt CSE represented by
stem–loops 3 and 4 downregulated the genome RNA replica-
tion in BHK-21 cells more than 10-fold to a barely detectable
level (Fig. 2B). The designed virus, VEEVubiΔ3+4, demon-
strated a high rate of evolution and formed heterogeneous
plaques immediately after transfection of RNA into BHK-21
and C710 cells. It was difficult to assess virus replication rates
(Figs. 2C and D), because heterogeneity of plaques formed by
viruses in the harvested samples suggested presence of multiple
variants. In addition, VEEVubiΔ3+4 was incapable of causing
any CPE in C710 cells at all. Based on the development of
plaques that strongly differed in size, we assumed that the
growth curves demonstrated in Figs. 2C and D did not represent
replication of the original construct, but more likely the
replication of the arising pseudorevertants. The restoration of
the 51-nt CSE was a highly unlikely event, and, therefore, we
expected the viruses to contain pseudoreverting mutations in the
genome fragments other than the 5′ end, most likely in the nsP
genes, whose products form the replication complex.
VEEVubiΔ3+4 accumulates adaptive mutations
VEEVubiΔ3+4 harvested after transfection of BHK-21 cells
was passaged twice in the same cells at an MOI of∼10 PFU/cell
to increase the concentration of the efficiently replicating variants
in the samples. To avoid isolation of the same variants, stocks
from two different transfection experiments were passaged
independently. Then large individual viral plaques were ran-
domly selected and the entire ns polyprotein-coding sequence
and the 3′ and 5′ ends of the genomes were sequenced. The
putative adaptive mutations were identified in all of the isolates.
They were found (i) in stem–loop 2 downstream of the initiating
AUG, (ii) in the nsP2 and (iii) in the nsP3 (Fig. 3). It is highly
unlikely that the small fragment of nsP1 encoded upstream of the
Ubi is involved in the replication complex formation or
functioning, and, therefore, the stem–loop 2-specific mutations
are presented as nucleotide, but not as a.a. changes. These
mutations affected the nucleotide sequence and the secondary
structure of stem–loop 2 and, thus, could be involved in
modulation of the promoter functioning (see following sections
Fig. 2. Replication of VEEVubi deletion mutants in BHK-21 and C710 cells. (A) Schematic representation of VEEVubi deletion mutants genomes and infectivities of
the in vitro-synthesized viral RNAs in the infectious center assay. Solid boxes indicate the nsP1 sequence containing clustered silent mutations. N.A. indicates “not
applicable,” because the mutant was incapable of forming plaques in C710 cells. (B) Synthesis of virus-specific RNAs in the transfected BHK-21 cells. At 2 h post
transfection with 3 μg of in vitro-synthesized RNA, viral RNAs were metabolically labeled with [3H]uridine for 6 h, as described in Materials and methods, and
analyzed by agarose gel electrophoresis. Positions of the genomic and subgenomic RNAs are indicated. (C and D) Single-step viral growth curves after electroporation
of 3 μg of in vitro-synthesized RNAs into BHK-21 and C710 cells. At the indicated times, the medium was replaced and virus titers determined in BHK-21 cells, as
described in Materials and methods. The dashed lines indicate the limit of detection.
Fig. 3. Mutations found in the VEEVubiΔ3+4 plaque isolates that became
capable of efficient replication in BHK-21 cells. The nucleotide changes in the
stem–loop 2 are indicated by lower-case letters. The a.a. changes identified in
nsP2 and nsP3 are indicated by upper-case letters.
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and nsP3, but their effect had to be evaluated in reverse genetics
experiments.
The adaptive mutations have synergistic effect on viral RNA
replication
Sequencing of the genome of efficiently replicating VEEV-
rev1 revealed a g116→u mutation in the 5′ end and another
mutation, E212→Q, in the nsP2. To understand the effect of
these mutations on virus replication, they were transferred either
separately or together into the VEEVubiΔ3+4 genome (Fig.
4A). The in vitro-synthesized RNAs were transfected into
BHK-21 and C710 cells, and the RNA infectivity was assessed
in the infectious center assay (Fig. 4A). We also examined virus
replication in both transfected cell cultures (Figs. 4B and C) and
viral RNA replication in BHK-21 cells (Fig. 4D). The mutation
in nsP2 had a strong stimulatory effect on virus growth. The
effect of g116→u replacement was less obvious, but it also
Fig. 4. Replication of VEEVubiΔ3+4 variants, containing the mutations identified in the efficiently replicating VEEVrev1 pseudorevertant, in BHK-21 and C710
cells. (A) Schematic representation of VEEVubiΔ3+4 genomes with different mutations and infectivities of the in vitro-synthesized viral RNAs in the infectious
center assay. Solid boxes indicate the nsP1 sequence containing clustered silent mutations. N.A. indicates “not applicable,” because the mutant was incapable of
forming plaques in C710 cells. (B and C) Single-step virus growth curves after electroporation of 3 μg of in vitro-synthesized RNAs into BHK-21 or C710 cells. At the
indicated times, the medium was replaced and virus titers were determined in BHK-21 cells, as described in Materials and methods. The dashed lines indicate the limit
of detection. (D) Synthesis of virus-specific RNAs in the transfected BHK-21 cells. At 2 h post transfection, viral RNAs were metabolically labeled with [3H]uridine
for 6 h, as described in Materials and methods, and analyzed by agarose gel electrophoresis. Positions of the genomic and subgenomic RNAs are indicated.
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compared to the original VEEVubiΔ3+4 at any time post
transfection. However, the results suggest that when combined,
the effects of these two mutations are additive and, thus, likely
affect different processes (Fig. 4D).
Other two pseudorevertants, VEEVrev2 and VEEVrev3, had a
common mutation G31→R in nsP3 (Fig. 3), but in the
VEEVrev2, this was the only mutation found, and VEEVrev3
developed two additional mutations a51→g in the 5′ terminus
and R568→H in the nsP2. The effect of these mutations was
tested by cloning their combinations into VEEVubiΔ3+4 (Fig.
5). In contrast to VEEVrev1, the mutation in nsP2 had no positive
effect either on RNA or virus replication, indicating that this was
likely a neutral change. However, both the 5′ end- and nsP3-
specific mutations strongly enhanced the virus replication,
because of a more efficient synthesis of viral genome and
transcription of the subgenomic RNA. Taken together these data
suggested that the negative effect of the deletion of the replication
enhancer in the VEEV genome can be neutralized bycompensatory mutations in the amino terminal domains of
nsP2 or nsP3, and the mutations in the RNA stem located in the
beginning of the ns ORF (stem–loop 2) can additionally
stimulate virus replication. Moreover, the stimulatory effect of
the mutations might be determined by different mechanisms.
To further test this hypothesis, we cloned into the VEEVu-
biΔ3+4 genome combinations the adaptive mutations found in
different plaque isolates (VEEVrev1 and VEEVrev2). Variants
containing only nsP2- and nsP3-specific mutations (E212→Q
and G31→R, respectively) or all of the mutations together
(E212→Q, G31→R and g116→u) replicated in BHK-21 cells as
efficiently as did the VEEVubi; however, a 1- to 2-h-long delay in
virus release was still noticeable at the early times, within the first
4 h post transfection (Fig. 6B). However, the finding of the same
infectivity for the in vitro-synthesized mutant and VEEVubi
RNAs, as well as the homogeneity of plaque size in the in the
infectious center assay indicates that further evolution either does
not proceed or does not have a critical effect on virus replication.
The cumulative effect of the mutations was readily detectable in
Fig. 5. Replication of VEEVubiΔ3+4 variants, containing the mutations identified in efficiently replicating VEEVrev2 and 3 pseudorevertants, in BHK-21 and C710
cells. (A) Schematic representation of VEEVubiΔ3+4 genomes with different mutations and infectivities of the in vitro-synthesized viral RNAs in the infectious
center assay. Solid boxes indicate the nsP1 sequence containing clustered silent mutations. N.A. indicates “not applicable,” because the mutant was incapable of
forming plaques in C710 cells. (B and C) Single-step virus growth curves after electroporation of 3 μg of in vitro-synthesized RNAs into BHK-21 or C710 cells. At the
indicated times, the medium was replaced and virus titers were determined in BHK-21 cells, as described in Materials and methods. The dashed lines indicate the
detection limit. (D) Synthesis of virus-specific RNAs in the transfected BHK-21 cells. At 2 h post transfection, viral RNAs were metabolically labeled with [3H]uridine
for 6 h, as described in Materials and methods, and analyzed by agarose gel electrophoresis. Positions of the genomic and subgenomic RNAs are indicated.
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(Figs. 6C and 7). Combining the nsP2- and nsP3-specific
mutations in the same genome increased viral RNA synthesis to
the level that we detected for the VEEVubi. The VEEV/Q+R and
VEEV/u+Q+R produced viral structural proteins and interfered
with cellular protein synthesis as efficiently as did VEEVubi,
having an intact 51-nt CSE. The inhibition of cellular translation
was even higher than that detected in the cells infected with
VEEV/u+Q or VEEV/R mutants. These results strongly indi-
cated that the nsP2- and nsP3-specific mutations functioned
independently and could synergistically stimulate RNA replica-
tion and, consequently, virus growth.
The adaptive mutations have positive effect on replication of
the VEEVubi
In the final experiments, we tested whether the identified
adaptive mutations function only in the context of a deleted 51-
nt CSE or if they have a stimulatory effect on replication ofviruses having the intact CSE as well. Therefore, we cloned
either E212→Q in nsP2 or both G31→R in nsP3 and E212→Q
in nsP2 into the VEEVubi genome (Fig. 8A). After transfection
of BHK-21 cells with the in vitro-synthesized RNA, we found
the double mutant to cause faster CPE, to synthesize more virus-
specific RNA (Fig. 8B) and, accordingly, to grow to almost 10-
fold higher titers than the original VEEVubi (Fig. 8C). Thus, the
mutations were capable of positively affecting the functions of
ns proteins not only in the context of the 51-nt CSE deletion
mutant, but also in the viruses having no changes in the 5′
promoter elements.
Discussion
Replication of the VEEV genome is determined not only by
functioning of the viral nsPs, but also by the promoters encoded
by the 3′ and 5′ ends of the viral genome RNA. In spite of great
efforts aimed at studying their organization and interaction with
the cellular and virus-specific proteins, these promoters are yet
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interesting elements of the RNA promoters. The RNA
sequence, located between nt 132 and 185 in the VEEV
genome, and corresponding amino acid sequence are conserved
among different alphaviruses. This RNA fragment is predicted
to form two short stem–loop structures in both positive and
negative strands of the viral genome. (If the latter minus-strand
RNA indeed exists in a free, but not in a double-stranded form.)
Moreover, the rare nucleotide differences found in the 51-ntFig. 7. Protein synthesis in BHK-21 cells infected with different variants of
VEEVubiΔ3+4. Cells were infected with the viruses indicated at an MOI of 10
PFU/cell. At 20 h post infection, they were labeled with [35S]methionine and
analyzed in a sodium dodecyl sulfate-10% polyacrylamide gel as described in
Materials and methods. Positions of VEEV-specific structural proteins and actin
are indicated.
Fig. 6. Replication of VEEVubiΔ3+4 variants, containing combinations of
mutations identified in efficiently replicating pseudorevertants, in BHK-21 and
C710 cells. (A) Schematic representation of VEEVubiΔ3+4 genomes with
different mutations and infectivities of the in vitro-synthesized viral RNAs in the
infectious center assay. Solid boxes indicate nsP1 sequence containing clustered
silent mutations. (B) Single-step viral growth curves after electroporation of
3 μg of in vitro-synthesized RNAs into BHK-21 cells. At the indicated times, the
medium was replaced and virus titers were determined in BHK-21 cells, as
described in Materials and methods. The dashed line indicates the detection
limit. (C) Synthesis of virus-specific RNAs in the transfected BHK-21 cells. At
2 h post transfection, viral RNAs were metabolically labeled with [3H]uridine
for 6 h, as described in Materials and methods, and analyzed by agarose gel
electrophoresis. Positions of the genomic and subgenomic RNAs are indicated.CSE of different alphaviruses are supplemented by compensa-
tory mutations that preserve the secondary structure of the RNA
stems, and this fact indirectly supports the existence of the
stem–loops and their importance in RNA replication (Niesters
and Strauss, 1990b). The 51-nt CSE is located in the nsP1-
coding sequence, and this complicates reverse genetics experi-
ments with this sequence. Only a limited number of manipula-
tions can be performed without affecting the encoded protein
sequence. For the most part, it is impossible to make any kind of
deletions in the context of the infectious cDNA. They can
certainly be done in the widely used defective alphavirus ge-
nomes (DI RNAs) (Frolov et al., 2001; Levis et al., 1986), for
which the replicative enzymes are supplied in trans by helper
virus or replicon, and, in this case, the effect of extended
mutations on DI RNA replication can be investigated. However,
the biological significance of such results is always question-
able. Therefore, to introduce the deletions into a 51-nt CSE of
VEEV genome, we made an attempt to separate the 5′ promoter
and the nsP-coding sequence. To achieve this, we inactivated
the original promoter by clustered silent mutations in the
beginning of the nsP1-coding sequence and cloned the
functional promoter upstream of this modified nsP1-coding
gene. In this recombinant virus genome, the ORF started from
Fig. 8. The effect of nsP2- and nsP3-specific mutations on replication of
VEEVubi. (A) Schematic representation of VEEVubi genomes with different
mutations and infectivities of the in vitro-synthesized viral RNAs in the
infectious center assay. Solid boxes indicate the nsP1 sequence containing
clustered silent mutations. (B) Synthesis of virus-specific RNAs in the
transfected BHK-21 cells. At 2 h post transfection, viral RNAs were
metabolically labeled with [3H]uridine for 6 h, as described in Materials and
methods, and analyzed by agarose gel electrophoresis. Positions of the genomic
and subgenomic RNAs are indicated. (C) Single-step virus growth curves after
electroporation of 3 μg of in vitro-synthesized RNAs into BHK-21 cells. At the
indicated times, the medium was replaced and virus titers were determined in
BHK-21 cells, as described in Materials and methods. The dashed line indicates
the detection limit.
483G. Michel et al. / Virology 362 (2007) 475–487the AUG in the cloned sequence and continued through this
short fragment of nsP1 and Ubi into the ns polyprotein. The
designed VEEVubi demonstrated growth characteristics that
were very similar to those of the wt VEEV TC-83 (Fig. 1). The
wt 51-nt CSE-containing fragment did not encode any protein
that could function in RNA replication, and was further
extensively modified in order to study the functioning of the
promoter elements in viral RNA replication. The same approach
did not work so unambiguously with SINV. The 97 silentmutations in the nsP1 did not make this virus incapable of
replication (Fig. 1). Therefore, it could be difficult to interpret
the effect of adaptive mutations, and work with SINVubi was
discontinued.
The studies of the 51-nt CSE deletion mutants suggested that
each of stem–loops in the VEEV-specific CSE and the 162 nt-
long sequence, located downstream from this element, could be
deleted without a strong negative effect on genome RNA
replication. However, without both stem–loops, the residual
activity of the promoter was insufficient for supporting
productive infection. These results can be explained by the
presence of more than one binding site for the proteins that are
involved in RNA replication (Pardigon et al., 1993; Pardigon
and Strauss, 1992), and the experiments that followed indicated
that these proteins may be of viral origin.
A low level of RNA replication created a productive
background for selection of mutants demonstrating a higher
replication efficiency. Such mutants appeared within the first
passages of the viral pool harvested after transfection of in vitro-
synthesized VEEVubiΔ3+4 genomes. We expected these
viruses to contain adaptive mutations in the promoter sequences.
To some extent, such was the case (Figs. 3 and 9A). In three
plaque isolates, point mutations were found in the large stem–
loop structure containing the initiating AUG, and no other
changes in the cloned 5′-terminal fragment were discerned.
These mutations stabilized computer-predicted RNA stem both
inminus-strand (Fig. 9A) and plus-strand (data not shown) of the
genome, and were localized in close proximity to each other,
suggesting the importance of this stem–loop in VEEVubiΔ3+4
RNA replication. However, the tested mutations were insuffi-
cient for increasing replication to the levels found for the
VEEVubi variant, which had an intact 51-nt CSE. Interestingly,
the detected g48→u replacement even created a stop codon
immediately downstream from the AUG, but the VEEVrev4
pseudorevertant was capable of efficient replication to a level
similar to that of the VEEVubi (data not shown).
The most important adaptive mutations that strongly
increased the synthesis of virus-specific RNA and accelerated
virus growth were detected, not in the 5′ end, but rather in the
nsP2 and nsP3 genes. The nsP2-specific mutations E212→Q and
E155→K (the effect of the latter mutation on RNA replication
was not tested in the reverse genetics experiments) were in the
sequence located between the predicted helicase domain and the
amino terminal domain that was suggested as a co-factor of the
nsP2-associated protease (Fig. 9C) (Vasiljeva et al., 2003). In our
previous studies, we developed a SINV variant having clustered,
silent mutations in the 5′-terminal sequence (which included the
51-nt CSE) that strongly affected the ability of virus to replicate
in the mosquito cells (Fayzulin and Frolov, 2004). The SINV
attained the mutations in the same sequence encoding a.a. 110–
215 of nsP2 (Fig. 9C) to become capable of replication in these
cells, and some of the mutations coincide with those found in the
VEEV nsP2. This protein fragment demonstrates a moderate
level of conservation between different alphaviruses (Fig. 9C),
and its function is not as yet well defined. Our data suggest that it
may be either an independent domain involved in the binding of
nsP2 (or the entire RC) to viral RNA or an integral part of the
Fig. 9. Sequence alignments and mutations found in VEEVrev1, VEEVrev2, VEEVrev3 and VEEVrev4 variants adapted for growth in BHK-21 cells. (A) Computer-
predicted (m-fold) structure (Jaeger et al., 1989) of the 3′ end of the minus-strand of VEEV genome. Arrows indicate mutations found in VEEVrev1, VEEVrev3 and
VEEVrev4. Triangle indicates the 51-nt CSE that is present in the minus strand of VEEVubi, but is deleted in VEEVubiΔ3+4. (B) Alignment of nsP3 residues 11 to 50
(VEEV numbering) for several alphaviruses. The mutation found in the VEEVrev2 and VEEVrev3 variants is indicated. (C) Alignment of nsP2 residues 101 to 240
(VEEV numbering). The mutations found in VEEVrev1 and VEEVrev4 and those previously detected in the genomes of SINVmutants adapted to growth in C710 cells
after mutagenesis of 51-nt CSE (Fayzulin and Frolov, 2004) are indicated. Arrows indicate putative positions of the RNA helicase domain and the aminoterminal co-
factor of nsP2-associated protease (Vasiljeva et al., 2003). VEEV, Venezuelan equine encephalitis virus (Kinney et al., 1989); EEEV, eastern equine encephalitis virus
(Weaver et al., 1993); SFV, Semliki Forest virus (Takkinen, 1986); SINV, Sindbis virus (Strauss et al., 1984). Residues identical to those in the VEEV sequence are
denoted by dashes.
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and RNA triphosphatase activities (Gomez de Cedron et al.,
1999; Rikkonen et al., 1994; Vasiljeva et al., 2000).
In contrast to mutations in nsP2, the adaptive mutations
accumulating in nsP3 in response to changes in the 5′-terminal
promoter elements are not closely localized. The identified
mutation in the VEEVrev2 and VEEVrev3 genomes was
G31→R (Fig. 9B). Its stimulatory effect was confirmed in the
reverse genetics experiments. AnothermutationD119→Gwas not
further studied, and, therefore, to date cannot be definitively
considered adaptive. Previously, we demonstrated that SINV
variants, which were incapable of replicating in C710 cells due to
clustered mutations in the 5′ terminus, attained the mutation
T286→ I in nsP3 (Fayzulin and Frolov, 2004). However, the latter
was incapable of enhancing RNA replication itself, had a
stimulatory effect only when introduced together with E118→K
in nsP2, and, thus, did not suggest an interaction of nsP3 with viral
RNA. In contrast, the nsP3-specific, G31→R mutation in the
VEEV genome was capable of strongly increasing viral and RNA
replicationwhen being introduced alone as well as in combination
with other adaptive mutations. The G31→R is located in the so-
calledX domain of nsP3 that is conserved among alphaviruses and
found in the rubella virus genome (Dominguez et al., 1990;
Strauss and Strauss, 1994), but its function has not yet been
defined. However, the present data suggest the possibility of its
involvement in RNA recognition by alphavirus RC.
Taken together, the data from this study, combined with the
previous results of the experiments with SINV (Fayzulin and
Frolov, 2004; Frolov et al., 2001; Gorchakov et al., 2004; Niesters
and Strauss, 1990b), suggest that the 51-nt CSE is a critical
element of the promoter that functions as a replication enhancer,most likely, by positioning the RC for efficient recognition of the
core promoter element. Based on the available data concerning
VEEV RNA replication, it is difficult to propose the exact
mechanism of its functioning, because this CSEmight be required
for plus- or minus- or both plus- and minus-strand RNA synthesis
(Frolov et al., 2001; Gorchakov et al., 2004; Pardigon et al., 1993;
Pardigon and Strauss, 1992). Moreover, it is also possible that the
changes in nsP2 and nsP3 function in the context of P123 rather
than in the mature, completely processed RC.
The core promoter is located in the 5′UTR (and its com-
plement in the 3′ terminus of the minus-strand intermediate), and
its very terminal nucleotides, having high concentration of
adenosines and uridines, are the most important for its activity in
both plus- and minus-strand RNA synthesis (Frolov et al., 2001;
Gorchakov et al., 2004). The deletion of the 51-nt CSE or
introduction of the clustered silent mutations into its sequence
strongly affects recognition of the core promoter by RC and
makes the RNA replication inefficient in the cells of both
vertebrate and invertebrate origin. Alphaviruses can adapt to the
loss of 51-nt CSE by changing the RNA-binding sequence in the
RC, which appears to be located within the amino terminal
∼215 a.a. of nsP2. Most of the found mutations either decrease
the number of the negatively charged amino acids and/or increase
that of the positively charged ones. The mutations in the
5′ terminus of the genome and in the nsP3 can also have positive
effects on replication of the 51-nt CSE mutants. This protein
creates large, high-order structures in the infected cells (Frolova et
al., 2006) and might be required either for changing the
positioning of the nsP2 or cellular proteins on the RNA.
Alternatively, it can directly interact with virus-specific RNAs.
At present, because of insufficient data, we cannot distinguish
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in the VEEV nsPs have also a positive effect on replication of the
virus with wt 51-nt CSE. It is highly unlikely that during its
previous evolution, VEEV did not develop the nsPs and the cis-
acting RNA elements supporting its efficient replication. An
additional increase in RNA replication could be either disadvan-
tageous for persistence of this virus in the mosquito vectors or
might have a negative effect on replication of this virus in the
vertebrate hosts due to a higher level of antiviral response caused
by the increased production of dsRNA. However, this hypothesis
needs further experimental support.
Such efficient adaptation of the alphaviruses to extended
changes of the promoter sequences not only additionally supports
the incredible plasticity of these viruses and their potential for
evolution. It also suggests that development of attenuated
alphaviruses and most likely other RNA-positive viruses for
vaccine applications by mutating their promoter elements should
be approached with caution, because of the rapid accumulation of




BHK-21 cells were obtained from Dr. Paul Olivo (Washing-
ton University, St. Louis, MO). They were propagated in Alpha
MEM (αMEM) supplemented with 10% fetal bovine serum
(FBS) and vitamins. Mosquito C710 cells were obtained from
Dr. Henry Huang (Washington University, St. Louis, MO).
They were propagated in DMEM supplemented with 10% heat-
inactivated FBS and 10% tryptose phosphate broth (TPB).
Plasmid constructs
The parental plasmid with VEEV TC-83 genome (Kinney et
al., 1993) was obtained from Dr. Richard Kinney (CDC, Fort
Collins, CO). The cDNA of the viral genome was cloned into a
low copy number plasmid that was previously used for SINV
genome (Rice et al., 1987) and the T7 promoter was replaced by
a promoter of SP6 RNA polymerase. The parental pToto1101
plasmid encoding an infectious wt SINV genome was described
elsewhere (Rice et al., 1987). All other plasmids encoding
genetically modified VEEV and SINV genomes were con-
structed by standard PCR-based mutagenesis and cloning
methods. All of the PCR fragments were sequenced to exclude
the possibility of spontaneous mutations. The details of the
designed constructs are described in Results and figure legends.
The details of the cloning procedures and sequences can be
provided upon request.
RNA transcriptions
Plasmids were purified by centrifugation in CsCl gradients.
Prior to transcription, the SINV and VEEV genome-coding
plasmids were linearized by XhoI andMluI, respectively. RNAs
were synthesized by SP6 RNA polymerase in the presence ofcap analog (Rice et al., 1987). The yield and integrity of the
transcripts were monitored by gel electrophoresis under non-
denaturing conditions. Three-microgram aliquots of the RNA
transcripts from the reaction mixtures were directly used for
electroporation (Liljeström et al., 1991).
RNA transfections and infectious center assay
In standard experiments, 3 μg of in vitro-synthesized, full-
length RNA transcripts was used per electroporation. Ten-fold
dilutions of electroporated BHK-21 or C710 cells were seeded
in 6-well tissue culture plates containing naive BHK-21 or C710
cells. After 2 h incubation at 37 °C (for BHK-21) or 30 °C (for
C710), BHK-21 cells were overlaid with 2 ml of 0.6% agarose
(Invitrogen) containing MEM supplemented with 3% FBS, and
C710 cells were overlaid with 2 ml of 0.6% tragacanth gum
(ICN) containing MEM supplemented with 5% heat-inactivated
FBS and 10% TPB. Plaques developed at 37 °C (in BHK-21
cells) or 30 °C (in C710 cells) and were stained with crystal
violet after 2–2.5 days of incubation. One-fifth of the
electroporated cells was seeded into 35-mm dishes for radio-
active labeling of RNAs or proteins. Another one-fifth was
seeded into the same size dishes to evaluate virus replication,
and the residual cells were used for generating viral stocks.
Selection of the pseudorevertants capable of efficient growth
The original stock of VEEVubiΔ3+4 was generated by
transfection of BHK-21 cells. It was passaged twice in BHK-
21 by infecting with 0.1 ml of the virus stock harvested after
the previous passage. After the last passage, the individual
large plaques were isolated from the agarose overlay, viruses
were eluted in 1.5 ml of αMEM supplemented with 1% FBS
for several hours, and 0.5 ml was used to infect 5×105 BHK-
21 cells in 35-mm dishes. Viruses were harvested after the
development of a profound cytopathic effect, and RNA was
isolated from the cells for sequencing of viral genomes. Four
plaque-purified viruses were randomly selected after passaging
of viral stocks obtained after independent electroporations.
Sequencing of viral genomes
RNAs isolated from the infected cells and the pelleted viruses
were used for RT-PCR and sequencing. Viruses were pelleted by
ultracentrifugation at 52,000 rpm for 1 h in a TLA-55 rotor at
4 °C in an Optima MAX ultracentrifuge (Beckman Coulter).
Pellets were suspended in 25 μl of PBS, and RNAs were isolated
by TRIzol using the procedure recommended by the manufac-
turer (Invitrogen). Ten overlapping (approximately 1 kb-long)
fragments representing the nonstructural genes and the 3′ end of
the viral genome were synthesized using an RT-PCR procedure,
purified by agarose gel electrophoresis and sequenced using the
same primers as those applied for PCR. (Sequences of the
primers can be provided upon request.) DNA fragments
representing the 5′-terminal sequences were synthesized using
a commercially available FirstChoice RLM-RACE Kit accord-
ing to the procedure recommended by the manufacturer
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esis and cloned into the plasmid pRS2. Multiple, independent
clones were sequenced to determine possible variations in the 5′
ends of the genomes.
Virus growth analysis
To exclude the effect of accumulation of additional adaptive
mutations, virus growth was analyzed directly after transfection
of 3 μg of RNAs into C710 or BHK-21 cells. One-fifth of the
electroporated cells was seeded into a 35-mm dish and incubated
at 37 °C (BHK-21 cells) or 30 °C (C710 cells) for 1 h. Then media
were replaced by 1 ml of fresh media, and it continued to be
replaced at indicated times post electroporation. Virus titers in the
harvested samples were determined by a plaque assay on BHK-
21 cells as described elsewhere (Lemm et al., 1990).
RNA analysis
One-fifth of the C710 cells electroporated with 3 μg of
different RNAs were seeded into 35-mm dishes and incubated at
37 °C. At 2 h post transfection virus-specific RNAs were labeled
by replacing the media with αMEM supplemented with 10%
FBS, [3H]uridine (20 μCi/ml) and 1 μg/ml of Dactinomycin
(ActD). RNAswere labeled for 6 h at 37 °C and isolated from the
cells by TRIzol reagent, as recommended by the manufacturer
(Invitrogen). Next, they were denaturedwith glyoxal in dimethyl
sulfoxide and analyzed by agarose gel electrophoresis in the
previously described conditions (Frolov et al., 2001).
Analysis of protein synthesis
BHK-21 cells were seeded into six-well Costar dishes at a
concentration of 5×105 cells/well. After 4 h incubation at 37 °C
in 5% CO2, they were infected at an MOI of 10 PFU/cell in
200 μl of PBS supplemented with 1%FBS for 1 h at 37 °C. The
inoculum was then replaced by complete medium, and
incubation continued at 37 °C for 20 h. Then cells were washed
three times with phosphate-buffered saline (PBS) and then
incubated for 45 min at 37 °C in 0.8 ml of DMEM medium
lacking methionine, supplemented with 0.1% FBS and 20 μCi/
ml of [35S]methionine. After this incubation, cells were scraped
into PBS, pelleted by centrifugation and dissolved in standard
gel-loading buffer. After electrophoresis, gels were dried and
analyzed by autoradiography.
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